Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
7 | 50479886 | non coding transcript exon variant | A/C;T | snv | 0.56; 1.6E-05 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
1.000 | 7 | 50495369 | missense variant | A/G | snv |
|
0.800 | 1.000 | 2 | 2004 | 2004 | ||||||||||
|
7 | 50482241 | intron variant | A/G | snv | 0.49 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
7 | 50477873 | intron variant | A/G | snv | 0.55 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
7 | 50477895 | intron variant | A/G | snv | 0.55 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
0.925 | 0.080 | 7 | 50482446 | intron variant | A/G | snv | 0.55 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||||
|
0.925 | 0.080 | 7 | 50482446 | intron variant | A/G | snv | 0.55 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
1.000 | 0.120 | 7 | 50501717 | intron variant | A/G | snv | 0.12 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
1.000 | 0.080 | 7 | 50461686 | intron variant | A/G | snv | 0.81 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2005 | 2005 | |||||||
|
0.882 | 0.120 | 7 | 50505635 | intron variant | A/G | snv | 0.36 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.882 | 0.120 | 7 | 50505635 | intron variant | A/G | snv | 0.36 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.882 | 0.120 | 7 | 50505635 | intron variant | A/G | snv | 0.36 |
|
0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.882 | 0.120 | 7 | 50502438 | intron variant | A/G | snv | 0.21 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.882 | 0.120 | 7 | 50502438 | intron variant | A/G | snv | 0.21 |
|
0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.882 | 0.120 | 7 | 50502438 | intron variant | A/G | snv | 0.21 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.120 | 7 | 50505011 | intron variant | A/T | snv | 0.35 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
1.000 | 0.120 | 7 | 50505011 | intron variant | A/T | snv | 0.35 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
1.000 | 0.120 | 7 | 50456510 | intron variant | C/A | snv | 7.5E-02 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
7 | 50477493 | intron variant | C/A | snv | 0.56 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
1.000 | 7 | 50463322 | missense variant | C/A | snv |
|
Pathological Conditions, Signs and Symptoms | 0.700 | 0 | ||||||||||||
|
1.000 | 7 | 50463322 | missense variant | C/A | snv |
|
Behavior and Behavior Mechanisms | 0.700 | 0 | ||||||||||||
|
1.000 | 7 | 50463322 | missense variant | C/A | snv |
|
Pathological Conditions, Signs and Symptoms | 0.700 | 0 | ||||||||||||
|
1.000 | 7 | 50463322 | missense variant | C/A | snv |
|
0.700 | 0 | |||||||||||||
|
1.000 | 7 | 50463322 | missense variant | C/A | snv |
|
0.700 | 0 | |||||||||||||
|
0.925 | 0.080 | 7 | 50539915 | missense variant | C/A;G | snv | 4.0E-06 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 |